Deans' stroke musings: Circulatory Mortality, Stroke, MI Predicted With AI-Enabled Retinal Vasculometry

Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Saturday, November 12, 2022

Circulatory Mortality, Stroke, MI Predicted With AI-Enabled Retinal Vasculometry

Once you've predicted this problem what is your solution to prevent the problem from happening? What research are you initiating for this?

Circulatory Mortality, Stroke, MI Predicted With AI-Enabled Retinal Vasculometry

AI-enabled retinal vasculometry has been identified as a noninvasive biomarker for the prediction of myocardial infarction, stroke, and circulatory mortality.

The use of artificial intelligence (AI)-enabled retinal vasculometry offers a noninvasive biomarker for the prediction of circulatory mortality, myocardial infarction (MI), and stroke, according to the results of a study published in the British Journal of Ophthalmology.

Researchers sought to examine whether the inclusion of AI-enabled retinal vasculometry improves existing risk algorithms for MI, incident stroke, and circulatory mortality.

AI-enabled retinal vessel image analysis processed images from a total of 88,052 participants from the UK Biobank (UKB), who were 40 to 69 years of age at image capture. Additionally, a total of 7411 participants from European Prospective Investigation into Cancer (EPIC)-Norfolk, who were aged 48 to 92 years at image capture, were included. Data on retinal arteriolar and venular width, area, and vessel tortuosity were obtained.

The researchers developed a fully automated AI-enabled system named QUARTZ (Quantitative Analysis of Retinal Vessels Topology and Size) for examining the retinal tree, which permits detailed vasculometry quantification in large population studies. The primary outcome was circulatory mortality, defined using ICD-10 codes.

The study included a total of 64,144 UKB participants who experienced 327 circulatory deaths and 5862 EPIC-Norfolk participants who experienced 201 circulatory deaths. The mean participant age in the UKB group was 56.8 years and the median follow-up was 7.7 years. In the EPIC-Norfolk group, the mean age was 67.6 years and the median follow-up was 9.1 years.